Factors associated with impaired color vision without retinopathy amongst people with type 2 diabetes mellitus: a cross-sectional study

• Published in: BMC endocrine disorders Vol. 17; no. 1; p. 29
• Main Authors: Tan, N C, Yip, W F, Kallakuri, S, Sankari, U, Koh, Y L E
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 02-06-2017; BioMed Central; BMC
• Subjects: Adult; Age Factors; Aged; Aged, 80 and over; Analysis; Blood pressure; Censuses; Cholesterol; Color blindness; Color vision; Color Vision Defects - epidemiology; Color Vision Defects - etiology; Color vision impairment; Cross-Sectional Studies; Diabetes; Diabetes mellitus; Diabetes Mellitus, Type 2 - complications; Diabetic retinopathy; Diagnosis; Electronic health records; Epidemiology; Eye; Female; Glucose tolerance; Glucose tolerance test; Health screening; High density lipoprotein; Humans; Internet; Logistic Models; Low density lipoprotein; Male; Medical screening; Middle age; Middle Aged; Population; Prevalence; Primary care; Quality of life; Retinopathy; Screening; Tolbutamide; Visual impairment; Color vision impairment; Screening; Diabetes mellitus
• ISSN: 1472-6823; 1472-6823
• DOI: 10.1186/s12902-017-0181-7

Patients with type 2 diabetes mellitus (T2DM) may develop color vision impairment. This study aimed to determine the prevalence and factors associated with impaired color vision in patients with T2DM but without diabetic retinopathy.
Enrolment criteria included multi-ethnic Asian participants, age 21 to 80 years, with known T2DM for a minimum of 2 years. Their diagnoses were affirmed from oral glucose tolerance test results and they were screened for impaired color vision using the Farnsworth D-15 instrument. Demographic characteristics were described and clinical data for the preceding 2 years were analyzed using logistic regression.
Twenty-two percent of 849 eligible participants had impaired color vision with higher involvement of the right eye. Impaired blue-yellow color-vision(Tritanomaly) was the commonest impaired color vision. Participants with impaired color vision were significantly associated with age and lower education; longer duration of T2DM (median 6 years vs 4 years); higher HbA1c level and HDL-Cholesterol in 2nd year; lower mean total cholesterol, mean LDL-Cholesterol and mean triglyceride in 2nd year. They also have poorer vision beyond 6/12 in the affected eye. Logistic regression showed that impaired color vision was associated with older patients (OR=1.04), increased duration of T2DM (OR=1.07); prescription of Tolbutamide (OR=3.79) and lower mean systolic blood pressure (OR=0.98).
Almost one in four participants with T2DM had impaired color vision, largely with tritanomaly. Color vision screening may be considered for participants who develop T2DM for 6 years or longer, but this requires further cost-effectiveness evaluation.